Oral Oncology Drugs Rife With Challenges

Pharmacy Practice News
ISSUE: JULY 2013 | VOLUME: 40

Los Angeles—In recent years, oral oncology agents have flooded the market, providing new therapeutic options. Although these drugs are seen as more convenient for patients, they come with a unique set of challenges, according to a panel of experts at the 2013 annual meeting of the Hematology/Oncology Pharmacy Association.

Food–drug and drug–drug interactions, limited access, reimbursement problems and monitoring requirements are all obstacles associated with oral cancer drugs, said panelist Robert Ignoffo, PharmD, a professor of pharmacy at Touro University California and a clinical professor emeritus at the University of California, San Francisco.

Continue reading this article on the Pharmacy Practice News website.